Annals of Saudi medicine
-
Annals of Saudi medicine · Sep 2023
Climate change and cutaneous leishmaniasis in the province of Ghardaïa in Algeria: A model-based approach to predict disease outbreaks.
Cutaneous leishmaniasis (CL) is a vector-borne disease prevalent in Algeria since 2000. The disease has significant impacts on affected communities, including morbidity and social stigma. ⋯ Incorporating additional reservoir statistics such as rodent density and a human development index in the region could improve our understanding of disease transmission.
-
Annals of Saudi medicine · Sep 2023
Selective anterior annuloplasty during inguinal herniotomy in boys: an approach to further reduce hernia recurrence.
Hernia recurrence is one of the most common complications after inguinal herniotomy (IH) in children. We describe a novel approach that involves adding anterior annuloplasty (AAP) during IH for selective high recurrence-risk children. ⋯ The study lacked a control group of patients to whom selective AAP would not be offered despite a high-recurrence risk. A prospective, controlled trial with a longer follow-up would lead to a stronger conclusion.
-
Annals of Saudi medicine · Sep 2023
The outcome of high-frequency oscillatory ventilation in pediatric patients with acute respiratory distress syndrome in an intensive care unit.
In adults with acute respiratory distress syndrome (ARDS), high-frequency oscillatory ventilation (HFOV) has been associated with higher mortality rates. Therefore, its use in children with ARDS is still controversial. ⋯ Retrospective single-center study.
-
Annals of Saudi medicine · Sep 2023
Observational StudyExperience with direct-acting antivirals in genotype 1-5 infected chronic hepatitis C patients in Turkey.
Hepatitis C virus (HCV) can cause chronic liver disease, hepatic cirrhosis, hepatocellular carcinoma, liver transplantation, and death. Early diagnosis and treatment are thus vital. ⋯ Retrospective, single-center.
-
Annals of Saudi medicine · Sep 2023
The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients.
The most common and lethal consequence of chronic kidney disease (CKD) is atherosclerotic cardiovascular disease. The persistent inflammation present in CKD increases hepcidin levels. Iron accumulates in the arterial wall in atherosclerosis. Hepcidin-25 was thought to accelerate the development of atherosclerotic plaques by blocking iron release from macrophages. Therefore, we sought to determine the relationship between hepcidin-25 and asymptomatic atherosclerosis in non-dialysis CKD patients. ⋯ Single-center.